Integrating Sglt-2 Inhibitors into the Clinical Management of Type 2 Diabetes Mellitus and Chronic Kidney Disease: Current Evidence and Future Outlook
Agus Layanto, Lely Kusumaningrum, Cynthia Arsita & Fenny Halim · Asian Journal of Medicine and Health · 2024
Objective and Background: The prevalence of type 2 diabetes mellitus (T2DM) is steadily increasing globally. A significant complication of T2DM is diabetic kidney disease, which contributes to increased morbidity and mortality. Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitors...
Open access
Research Article
10.9734/ajmah/2024/v22i121139